During the past decade, Mercy Medical Research Institute conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 45 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 21 clinical trials were completed. i.e. 700% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mercy Medical Research Institute" #1 sponsor was "Boston Scientific Corporation" with 5 trials, followed by "Bristol-Myers Squibb" with 5 trials sponsored, "Celgene" with 5 trials sponsored, "Pfizer" with 4 trials sponsored and "Allergan" with 4 trials sponsored. Other sponsors include 40 different institutions and companies that sponsored additional 42 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy Medical Research Institute" #1 collaborator was "AbbVie" with 1 trials as a collaborator, "Clinipace Worldwide" with 1 trials as a collaborator, "German Low Grade Lymphoma Study Group" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator and "Institute of Cancer Research, United Kingdom" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Mercy Medical Research Institute" are "Chronic Pain" (5 trials), "Diabetes Mellitus, Type 2" (3 trials), "Migraine" (3 trials), "Migraine Headache" (3 trials) and "Obesity" (3 trials). Many other conditions were trialed in "Mercy Medical Research Institute" in a lesser frequency.

Most popular intervention types in "Mercy Medical Research Institute" are "Drug" (50 trials), "Device" (10 trials), "Other" (6 trials), "Biological" (5 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "placebo" (3 trials), "Ancillary therapy" (2 trials), "Azacitidine" (2 trials) and "Cyclophosphamide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Mercy Medical Research Institute" are 66 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Mercy Medical Research Institute". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 47 completed trials in Mercy Medical Research Institute, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Mercy Medical Research Institute, 0 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 35 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 8 trials that are defined as “Not Applicable".